Orion/Novartis Entacapone "Does Not Appear To Be Hepatotoxic" - CPMP
Executive Summary
Orion/Novartis' Parkinson's therapy entacapone does not appear to have significant liver toxicity, the Committee for Proprietary Medicinal Products concluded at its Nov. 17-19 meeting in London.